Indian Generics Market Surging Ahead with a 17% Growth

The Indian generic drugs market will grow at a CAGR of around 17% during FY 2011-2013, acknowledged RNCOS.

Noida, India (prHWY.com) February 29, 2012 - The Indian generic drugs market has been witnessing rapid growth on the back of greater acceptance and penetration of generics, high export opportunities and global demand, and large share of off-patent drugs in the future. The market growth is also getting fuelled by the rising interest of global and foreign players for investments in India. India has become an important landmark in the filed of generics globally and the scope for growth of the Indian generics sector is huge, says our new research report, "Booming Generics Drug Market in India".

Our research identified that the global opportunities are prime in the growth of the Indian generics market. Countries, such as US, Europe, Japan, and Africa offer immense opportunities to Indian drug manufacturers. In 2010, Indian drug manufacturers held a 10.5% share in the US generics market. Europe also represents a huge market opportunity for India and the demand for API's in Europe is of particular attraction. In Japan too, there are a plethora of opportunities for Indian generics manufacturers as increasing generics penetration is one of government's top priority. Further, the free trade agreement between India and Japan is another thumbs-up for Indian Generics. Indian exports to African regions have also shown a steady growth and is expected to grow further in the future. Thus, the Indian generic drugs market is projected to grow at a CAGR of around 17% during FY 2011-2013.

The Indian generics sector has showcased several upcoming market trends that are expected to govern the industry. Rural programmes and initiatives for generics has become a major focus and several leading market players have taken initiatives in recent times to promote generics in these regions. Investments and new drug launches in biogenerics is also becoming more prevalent. Indian drug makers are focusing on the export of API's due to high demand cross the globe. Also significant strategic alliances and M&A's have characterized the Indian generic market in recent times.

Our report "Booming Generics Drug Market in India" analyses the generics market in the country prudently and provides a complete evaluation of its current and future market scenario. It highlights the key market drivers and analyses the industry performance holistically. It provides a future analysis of the market along with the key forecasts. Further, it assesses the opportunities provided by some of the important countries across the globe for Indian Generics. It summarizes some of the restraints experienced by the industry and also briefs the regulatory scenario in the country. Finally, analysis on the key market players thus provides a complete and coherent understanding of the market to the reader.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM256.htm

Some of our Related Reports are:

- Generic Drug Market in Canada (http://www.rncos.com/Report/IM598.htm)
- UK Generics Market Analysis (http://www.rncos.com/Report/IM313.htm)
- Japanese Generic Market Forecast to 2013
(http://www.rncos.com/Report/IM170.htm)
- Booming US Generic Drug Market (http://www.rncos.com/Report/IM589.htm)
- Brazil Generics Market Forecast to 2012 (http://www.rncos.com/Report/IM249.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

About RNCOS

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behaviour. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.

###

Tag Words: india generics market

Categories: Health

Press Release Contact
B-129, Sector 6 Noida - 201301
91-120-4224-700
91-120-4224-707

Link To This Press Release:

URL HTML Code